These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9862411)

  • 1. Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors.
    Sargent PA; Quested DJ; Cowen PJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):120-2. PubMed ID: 9862411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
    Meltzer H; Bastani B; Jayathilake K; Maes M
    Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain 5-HT neurotransmission during paroxetine treatment.
    Sargent PA; Williamson DJ; Cowen PJ
    Br J Psychiatry; 1998 Jan; 172():49-52. PubMed ID: 9534832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept.
    Jacobsen JP; Rudder ML; Roberts W; Royer EL; Robinson TJ; Oh A; Spasojevic I; Sachs BD; Caron MG
    Neuropsychopharmacology; 2016 Aug; 41(9):2324-34. PubMed ID: 26932820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
    Meltzer HY; Maes M
    Psychopharmacology (Berl); 1994 May; 114(4):635-43. PubMed ID: 7855226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCD: where the serotonin selectivity story begins.
    Pigott TA
    J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT2A receptor response.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Nov; 55(3):387-96. PubMed ID: 8951980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.
    Lee MA; Nash JF; Barnes M; Meltzer HY
    Psychopharmacology (Berl); 1991; 103(2):258-64. PubMed ID: 1851310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
    Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine responses to serotonergic agents in alcoholics.
    Lee MA; Meltzer HY
    Biol Psychiatry; 1991 Nov; 30(10):1017-30. PubMed ID: 1756196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute clomipramine exposure elicits dose-dependent surfacing behavior in adult zebrafish (
    Shafiq A; Andrade M; Matthews R; Umbarger A; Petrunich-Rutherford ML
    PeerJ; 2024; 12():e17803. PubMed ID: 39040938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine: clinical overview.
    Gorman JM
    J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
    Sémont A; Fache M; Héry F; Faudon M; Youssouf F; Héry M
    J Neuroendocrinol; 2000 Aug; 12(8):736-44. PubMed ID: 10929085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effect of clomipramine through interaction with serotonin 5-HT2 and 5-HT3 receptor subtypes.
    Kostadinov ID; Delev DP; Kostadinova II
    Folia Med (Plovdiv); 2012; 54(4):69-77. PubMed ID: 23441472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.